|
|
nuclear transcribed mrna catabolic process exonucleolytic
|
GO:0000291 |
7 |
0.949
|
|
|
|
rna phosphodiester bond hydrolysis exonucleolytic
|
GO:0090503 |
14 |
0.808
|
|
|
|
rna catabolic process
|
GO:0006401 |
71 |
0.689
|
|
|
|
ncrna catabolic process
|
GO:0034661 |
14 |
0.667
|
|
|
|
maturation of 5 8s rrna
|
GO:0000460 |
8 |
0.636
|
|
|
|
rna phosphodiester bond hydrolysis
|
GO:0090501 |
35 |
0.574
|
|
|
|
mrna catabolic process
|
GO:0006402 |
56 |
0.531
|
|
|
|
nuclear rna surveillance
|
GO:0071027 |
4 |
0.517
|
|
|
|
exonucleolytic nuclear transcribed mrna catabolic process involved in deadenylation dependent decay
|
GO:0043928 |
6 |
0.504
|
|
|
|
trna catabolic process
|
GO:0016078 |
1 |
0.445
|
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
116 |
0.445
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.404
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.349
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.336
|
|
|
|
ribosome biogenesis
|
GO:0042254 |
48 |
0.335
|
|
|
|
rrna metabolic process
|
GO:0016072 |
40 |
0.327
|
|
|
|
nuclear ncrna surveillance
|
GO:0071029 |
2 |
0.313
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.290
|
|
|
|
ncrna metabolic process
|
GO:0034660 |
108 |
0.264
|
|
|
|
polyadenylation dependent rna catabolic process
|
GO:0043633 |
3 |
0.260
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.247
|
|
|
|
nuclear transcribed mrna catabolic process
|
GO:0000956 |
48 |
0.245
|
|
|
|
maturation of 5 8s rrna from tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000466 |
2 |
0.240
|
|
|
|
ncrna processing
|
GO:0034470 |
83 |
0.218
|
|
|
|
nuclear polyadenylation dependent rrna catabolic process
|
GO:0071035 |
2 |
0.215
|
|
|
|
dna catabolic process
|
GO:0006308 |
49 |
0.201
|
|
|
|
dna deamination
|
GO:0045006 |
9 |
0.197
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.147
|
|
|
|
nuclear polyadenylation dependent ncrna catabolic process
|
GO:0071046 |
2 |
0.147
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
37 |
0.136
|
|
|
|
trna metabolic process
|
GO:0006399 |
35 |
0.136
|
|
|
|
polyadenylation dependent mrna catabolic process
|
GO:0071047 |
1 |
0.122
|
|
|
|
rrna catabolic process
|
GO:0016075 |
6 |
0.110
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.105
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.099
|
|
|
|
neuronal action potential
|
GO:0019228 |
9 |
0.096
|
|
|
|
ncrna 3 end processing
|
GO:0043628 |
4 |
0.094
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.094
|
|
|
|
rrna processing
|
GO:0006364 |
35 |
0.090
|
|
|
|
system process
|
GO:0003008 |
349 |
0.089
|
|
|
|
rna 3 end processing
|
GO:0031123 |
35 |
0.087
|
|
|
|
rna surveillance
|
GO:0071025 |
5 |
0.086
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.083
|
|
|
|
action potential
|
GO:0001508 |
34 |
0.083
|
|
|
|
polyadenylation dependent ncrna catabolic process
|
GO:0043634 |
2 |
0.080
|
|
|
|
growth
|
GO:0040007 |
202 |
0.079
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.079
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.076
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.075
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.075
|
|
|
|
dosage compensation
|
GO:0007549 |
3 |
0.074
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.073
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.067
|
|
|
|
cut metabolic process
|
GO:0071043 |
3 |
0.066
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.064
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.063
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
11 |
0.058
|
|
|
|
snrna metabolic process
|
GO:0016073 |
15 |
0.053
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.051
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.051
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.051
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.049
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.048
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.046
|
|
|
|
head development
|
GO:0060322 |
108 |
0.043
|
|
|
|
nuclear polyadenylation dependent mrna catabolic process
|
GO:0071042 |
1 |
0.043
|
|
|
|
nuclear mrna surveillance
|
GO:0071028 |
4 |
0.042
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.041
|
|
|
|
execution phase of apoptosis
|
GO:0097194 |
32 |
0.040
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.040
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.039
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.039
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.037
|
|
|
|
histone mrna catabolic process
|
GO:0071044 |
10 |
0.037
|
|
|
|
snrna processing
|
GO:0016180 |
14 |
0.037
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
34 |
0.034
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.034
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.033
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.033
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.033
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.033
|
|
|
|
myelination
|
GO:0042552 |
6 |
0.032
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.031
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.031
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.031
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.029
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.029
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.027
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.025
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.024
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.024
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.023
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.023
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.023
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.023
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.023
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.022
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.022
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.021
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.021
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.020
|
|
|
|
axon ensheathment
|
GO:0008366 |
6 |
0.020
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.020
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.020
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.019
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.019
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.019
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.019
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.019
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.019
|
|
|
|
phagocytosis
|
GO:0006909 |
42 |
0.019
|
|
|
|
cut catabolic process
|
GO:0071034 |
3 |
0.018
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.018
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
48 |
0.018
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.018
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.018
|
|
|
|
negative regulation of phosphatase activity
|
GO:0010923 |
61 |
0.018
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.018
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.017
|
|
|
|
regulation of meiosis
|
GO:0040020 |
3 |
0.017
|
|
|
|
apoptotic dna fragmentation
|
GO:0006309 |
6 |
0.017
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.017
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.017
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.017
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.017
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.017
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.016
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.016
|
|
|
|
protein deubiquitination
|
GO:0016579 |
79 |
0.016
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.016
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.015
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.015
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.015
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.015
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.015
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.015
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.014
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.014
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.014
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.014
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.014
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.014
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.014
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.014
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.014
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.013
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.013
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.013
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.013
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.013
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.013
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.013
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.013
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.013
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.013
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.013
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.013
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.013
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.013
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.012
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.012
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.012
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.012
|
|
|
|
snorna metabolic process
|
GO:0016074 |
1 |
0.012
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.012
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.012
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
92 |
0.012
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.012
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.012
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.012
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.012
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.012
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.012
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.012
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.012
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.012
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.012
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.012
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.012
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.011
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.011
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.011
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.011
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.011
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.011
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.011
|
|
|
|
cellular component disassembly involved in execution phase of apoptosis
|
GO:0006921 |
13 |
0.011
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.011
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.011
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.011
|
|
|
|
apoptotic nuclear changes
|
GO:0030262 |
13 |
0.011
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.011
|
|
|
|
regulation of phosphatase activity
|
GO:0010921 |
81 |
0.011
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.011
|
|
|
|
memory
|
GO:0007613 |
3 |
0.011
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.011
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.011
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.010
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.010
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.010
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.010
|
|
|
|
golgi vesicle transport
|
GO:0048193 |
80 |
0.010
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.010
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.010
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.010
|
|